Biblio Discovery — Demo Discovery Service

9 hasil untuk "Matthieu Duchmann"

Menampilkan 1–9 · 1,27 detik · RSS

  1. Artikel Jurnal

    Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r

    Augustin Boudry; Sasha Darmon; Nicolas Duployez dkk.

    BMC Bioinformatics, Vol. 23 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Background Internal tandem duplications in the FLT3 gene, termed FLT3-ITDs, are useful molecular markers in acute myeloid leukemia (AML) for patient risk stratification and follow-up. FLT3-ITDs are increasingly screened through high-throughput sequencing (HTS) raising the need for robust…

  2. Artikel Jurnal

    Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine

    Lin-Pierre Zhao; Typhaine Dumas-Rivero; Lauren Barette dkk.

    Blood Advances, Vol. 9 No. 14 · 2025 · Inggris · DOAJ Scopus

    Abstract: The prognostic impact of monocytic differentiation in patients with acute myeloid leukemia (AML) receiving venetoclax (Ven) and azacitidine (Aza) remains unclear. In a prospective cohort of 86 newly diagnosed patients with AML treated with Ven-Aza, we used multiparametric flow cytometry…

  3. Artikel Jurnal

    Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents

    Matthieu Duchmann; Fevzi F. Yalniz; Alessandro Sanna dkk.

    EBioMedicine, Vol. 31 · 2018 · Inggris · DOAJ Scopus

    Somatic mutations contribute to the heterogeneous prognosis of chronic myelomonocytic leukemia (CMML). Hypomethylating agents (HMAs) are active in CMML, but analyses of small series failed to identify mutations predicting response or survival. We analyzed a retrospective multi-center cohort of 174…

  4. Artikel Jurnal

    Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers

    Sabine Khalife-Hachem; Khalil Saleh; Florence Pasquier dkk.

    HemaSphere, Vol. 5 No. 9 · 2021 · Inggris · DOAJ Scopus

    Definition of therapy-related myeloid neoplasms (TRMN) is only based on clinical history of exposure to leukemogenic therapy. No specific molecular classification combining therapy-related acute myeloid leukemia and therapy-related myelodysplastic syndromes has been proposed. We aimed to describe…

  5. Artikel Jurnal

    A multiparametric niche-like drug screening platform in acute myeloid leukemia

    Reinaldo Dal Bello; Justine Pasanisi; Romane Joudinaud dkk.

    Blood Cancer Journal, Vol. 12 No. 6 · 2022 · Inggris · DOAJ Scopus

    Abstract Functional precision medicine in AML often relies on short-term in vitro drug sensitivity screening (DSS) of primary patient cells in standard culture conditions. We designed a niche-like DSS assay combining physiologic hypoxia (O2 3%) and mesenchymal stromal cell (MSC) co-culture with…

  6. Artikel Jurnal

    Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients

    Adriane Halik; Marlon Tilgner; Patricia Silva dkk.

    Journal of Hematology & Oncology, Vol. 17 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Background Deletions and partial losses of chromosome 7 (chr7) are frequent in acute myeloid leukemia (AML) and are linked to dismal outcome. However, the genomic landscape and prognostic impact of concomitant genetic aberrations remain incompletely understood. Methods To discover genetic…

  7. Artikel Jurnal

    Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

    Michael Loschi; Marie-Charlotte Villy; Jacques-Emmanuel Galimard dkk.

    Blood Advances, Vol. 9 No. 24 · 2025 · Inggris · DOAJ Scopus

    Abstract: Germ line DDX41 mutations (DDX41mut) are identified in ∼5% of myeloid malignancies with an excess of blasts, representing a distinct myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) entity. The disease is associated with better outcomes than DDX41 wild-type (DDX41WT) cases, but…